SP

Simon Puttick

Chief Technology Officer

AdvanCell Isotopes Pty Ltd

Brisbane, Queensland


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
AdvanCell Isotopes Pty Ltd
Industry
research
Employees
57.0
Seniority
C suite
Annual Revenue
2000000.0
Total Funding
124398598.0
Latest Funding
Series C

Technologies

Outlook Microsoft Office 365 Amazon AWS Vimeo Mobile Friendly reCAPTCHA Remote IoT Basis AI

Keywords

radiopharmaceuticals radioligand discovery 212pb biotechnology biopharmaceuticals changing the course of cancer biotechnology research targeted alpha therapy alpha isotopes prostate cancer cancer treatment quality of life clinical trials isotope supply chain nuclear medicine advanced cancer therapies gmp standards active pharmaceutical ingredient pb generator isotope production therapeutic development clinical development radioligand therapy oncology drug development lead-212 alpha emitters cancer patients scalable solutions pb-advc001 advc002 advc003 pharmaceutical manufacturing nuclear materials science end-to-end solution radiochemical processing innovative therapeutics research & development theranostics molecular imaging companion diagnostics regulatory affairs translational research clinical operations partnership programs cml compliance gmp manufacturing educational partnerships fda requirements preclinical validation safe radiopharmaceutical distribution clinical trial applications therapeutics in oncology health care health wellness & fitness hospital & health care pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans